Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Antibody Cocktails Market

Published Date : Feb 2022

An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response to the presence of a foreign substance, called an antigen. Antigens are a wide range of substances that include disease-causing organisms and toxic m... View more

Coherent Market Insights Pyrimethamine Market

Published Date : Feb 2022

Pyrimethamine is a medicine used to treat protozoan infections. Pyrimethamine belongs to a class of drugs known as antiparasitics. It works by killing parasites. It is commonly used as an antimalarial (for the treatment and prevention of malaria), as well as to treat ... View more

Coherent Market Insights Uae Ivf Drugs And Food Supplements Market

Published Date : Feb 2022

In vitro fertilization (IVF) is a form of assisted reproductive technology in which a woman’s reproductive system is artificially stimulated to produce oocytes, which are extracted, fertilized in a laboratory, and then implanted in the uterus. This is a multiste... View more

Coherent Market Insights Us Triptorelin Market

Published Date : Feb 2022

Triptorelin is a gonadotropin releasing hormone (GnRH) agonist, it is an inhibitor of synthesis of testosterone (in men) and estrogen (in women), which is used for the treatment of central precocious puberty (CPP) and advanced prostate cancer. According to the Nationa... View more

Coherent Market Insights Tcv Vaccines Market

Published Date : Feb 2022

Typbar TCV vaccine is a typhoid vaccine recommended for the prevention of typhoid fever. Typbar TCV vaccine works by causing the body to produce its own protection (antibodies) against the bacteria. This vaccine is generally recommended for individuals who are traveli... View more

Coherent Market Insights Plasma Derived Medicine Market

Published Date : Feb 2022

Plasma-derived medicinal products are pharmaceuticals or medicines produced from human plasma which is the liquid portion of the blood and consists of approximately 90% water. It contains over 120 different proteins that take on functions vital to life, such as fighti... View more

Coherent Market Insights Us Ophthalmic Compounding Pharmacies Market

Published Date : Feb 2022

When a commercially available medicine does not fit the unique needs of an individual patient (human or animal), the drug is compounded by a certified pharmacist. When a patient may be unable to tolerate a commercially available drug, or when the particular formulatio... View more

Coherent Market Insights Middle East And Turkey Chronic Liver Disease Therapeutics Market

Published Date : Feb 2022

Chronic liver disease is associated with the progressive destruction of liver parenchyma for longer period of time (6 months) leading to liver fibrosis and cirrhosis. The main etiology of CLD include alcohol induced liver, hepatitis virus (B, C, and D), hepatocellular... View more

Coherent Market Insights Allergy Immunotherapy Market

Published Date : Feb 2022

Immunotherapy is a preventive treatment for allergic reaction to substance such as grass pollens, house dust mites, and bee venom. Subcutaneous immunotherapy (SCIT) and Sublingual immunotherapy (SLIT) are the immunotherapies used f... View more

Coherent Market Insights Nigeria Neuropathic Pain Management Drugs Market

Published Date : Feb 2022

Neuropathic pain is a complex, long-term pain condition that is frequently accompanied by tissue damage. It may cause nerve fiber damage which results in failure in signal transmission to  pain centers. A nerve fiber injury causes a change in nerve function both ... View more

Coherent Market Insights Meningococcal Disease Treatment Market

Published Date : Feb 2022

Meningococcal infection is a bacterial infection caused by Neisseria meningitidis, also known as meningococcus, a gram-negative bacterium. Meningococcal meningitis is a serious infection of the thin lining that surrounds the brain and spinal cord. ... View more

Coherent Market Insights North America Portable Alcohol And Drug For Abuse Testing Equipment Market

Published Date : Feb 2022

Abuse of alcohol and drugs is a huge threat to society. Although the majority of users are harmless, the dangers of drunk driving and occupational accidents need the implementation of some limitations. As the dangers become more widely known and the capacity to detect... View more

Coherent Market Insights Lyophilized Product Market

Published Date : Feb 2022

Lyophilization or freeze drying is the process in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a l... View more

Coherent Market Insights Addiction Treatment Market

Published Date : Jan 2022

Addiction is a chronic condition which gives rise to psychological and physical damage. People who suffer from an addiction have an uncontrollable desire and lack of resistance to use lethal substances or to involve in harmful activities in spite of knowing their nega... View more

Coherent Market Insights High Level Disinfection Services Market

Published Date : Dec 2021

Failure to perform proper disinfection and sterilization of medical devices may lead to introduction of pathogens, resulting in infection. High-level disinfection traditionally is defined as complete elimination of all microorganisms in or on an instrument, except for... View more

Coherent Market Insights Asia Pacific Generic Oncology Sterile Injectable Market

Published Date : Dec 2021

Generic oncology sterile injectables are used for the treatment of various types of cancers such as ovarian, breast, and lung. Generic oncology sterile injectable products are relatively cheaper than branded counterparts. Treatment cost is a major concern for cancer p... View more

Coherent Market Insights Oncology Radiopharmaceuticals Market

Published Date : Dec 2021

Radiopharmaceuticals are medications that contain radioactive (isotopes), which are used for the treatment or diagnose of cancer. These medications can be administered into patient’s body orally, intravenously or interstitially (inserted into a cavity in the bod... View more

Coherent Market Insights Targeted Therapy Market

Published Date : Dec 2021

Targeted therapy is used individually and in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy. It is the foundation of precision medicine. Targeted therapies are divided into two classes such as small molec... View more

Coherent Market Insights Avascular Necrosis Market

Published Date : Dec 2021

Avascular necrosis is a disease that results from the short-term or permanent loss of blood supply to the bone. This cut-off of blood supply to bone leads to tiny breaks in the bone and the bones eventually collapse. Avascular necrosis is also known as osteonecrosis. ... View more

Coherent Market Insights Us Intravenous Immunoglobulin Market

Published Date : Dec 2021

Intravenous immune globulin (IVIG) is an antibody-based product that can be administered intravenously (through a vein). Intravenous immunoglobulin (IVIG) is a blood product made from the serum of 1,000 to 15,000 donors per batch. It is a preferred treatment for the p... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.